+2,838.9%
KLAC vs CVS
+42.0%
+2,797.0%
-43.6%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 10y.
| Period | Portfolio | CVS | Excess | Alpha |
|---|---|---|---|---|
| 1D | -3.1% | -0.1% | -3.0% | -3.1% |
| 7D | +2.5% | -2.0% | +4.4% | +3.0% |
| 30D | -11.5% | +1.9% | -13.4% | -12.1% |
| 3M | -16.9% | -2.2% | -14.8% | -16.7% |
| 6M | +22.2% | +26.7% | -4.5% | +13.9% |
| YTD | +46.4% | +22.9% | +23.5% | +36.5% |
| 1Y | +91.0% | +32.9% | +58.1% | +73.9% |
| 3Y | +264.6% | +62.3% | +202.3% | +199.3% |
| 5Y | +430.6% | +34.2% | +396.3% | +364.0% |
| All | +2,838.9% | +42.0% | +2,797.0% | +2,152.3% |
Cumulative growth
Daily Returns
Daily percentage return beside CVS.
Daily Out/Under-Performance
Portfolio return minus CVS return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × CVS return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 10y: compounded portfolio wealth divided by compounded CVS wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
10y analysis · Full analysis span regression · 6 months rolling